TROY E. MESSICK,PAUL M. LIEBERMAN,GARRY R. SMITH,ARLINDO L. CASTELHANO
申请号：
US16414198
公开号：
US20190352285A1
申请日:
2019.05.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates, in certain aspects, to developable forms of certain compounds that are useful to treat and/or prevent EBV infection and related conditions in a subject. The invention further provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection.
